Neuberger Berman Group LLC Eli Lilly & CO Transaction History

Neuberger Berman Group LLC

$118 Billion
Q1 2024

A detailed history of Neuberger Berman Group LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Neuberger Berman Group LLC holds 1,392,331 shares of LLY stock, worth $1.14 Billion. This represents 0.92% of its overall portfolio holdings.

Number of Shares

1,392,331

Holding current value

$1.14 Billion

% of portfolio

0.92%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$592.2 - $792.28 $825 Million - $1.1 Billion	1,392,331 New	1,392,331 $1.08 Billion
Q4 2023 Feb 09, 2024	SELL	$525.19 - $619.13 $29.7 Million - $35.1 Million	-56,618 Reduced 3.77%	1,447,060 $844 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $15.4 Million - $21.2 Million	35,344 Added 2.41%	1,503,678 $808 Million
Q2 2023 Aug 11, 2023	BUY	$350.74 - $468.98 $21.8 Million - $29.2 Million	62,222 Added 4.43%	1,468,334 $689 Million
Q1 2023 May 12, 2023	BUY	$310.63 - $364.82 $23.4 Million - $27.4 Million	75,211 Added 5.65%	1,406,112 $483 Million

Q4 2022 Feb 13, 2023	SELL	$321.55 - $374.67 $6.69 Million - $7.8 Million	-20,815 Reduced 1.54%	1,330,901 $487 Million
Q3 2022 Nov 15, 2022	SELL	$296.48 - $337.87 $6.22 Million - $7.09 Million	-20,985 Reduced 1.53%	1,351,716 $437 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $12 Million - $14.1 Million	42,989 Added 3.23%	1,372,701 $445 Million
Q1 2022 May 13, 2022	BUY	$234.69 - $291.66 $8.07 Million - $10 Million	34,396 Added 2.66%	1,329,712 $377 Million
Q4 2021 Feb 11, 2022	BUY	$224.85 - $279.04 $89.9 Million - $112 Million	399,841 Added 44.65%	1,295,316 $355 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $6.58 Million - $8.1 Million	-29,700 Reduced 3.21%	895,475 $205 Million
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $7.48 Million - $9.67 Million	41,419 Added 4.69%	925,175 $211 Million
Q1 2021 May 13, 2021	SELL	$164.32 - $212.72 $11.2 Million - $14.5 Million	-68,319 Reduced 7.18%	883,756 $165 Million
Q4 2020 Feb 10, 2021	SELL	$130.46 - $172.63 $5.62 Million - $7.44 Million	-43,085 Reduced 4.33%	952,075 $161 Million
Q3 2020 Nov 12, 2020	BUY	$146.22 - $169.13 $3.98 Million - $4.61 Million	27,246 Added 2.81%	995,160 $147 Million
Q2 2020 Aug 13, 2020	SELL	$136.42 - $164.18 $395,754 - $476,286	-2,901 Reduced 0.3%	967,914 $159 Million
Q1 2020 May 14, 2020	BUY	$119.05 - $147.35 $3.88 Million - $4.8 Million	32,585 Added 3.47%	970,815 $135 Million
Q4 2019 Feb 12, 2020	SELL	$106.92 - $132.43 $1.93 Million - $2.39 Million	-18,033 Reduced 1.89%	938,230 $123 Million
Q3 2019 Nov 13, 2019	SELL	$106.79 - $116.16 $20.7 Million - $22.5 Million	-193,809 Reduced 16.85%	956,263 $107 Million
Q2 2019 Aug 13, 2019	SELL	$110.79 - $129.32 $6.87 Million - $8.02 Million	-62,041 Reduced 5.12%	1,150,072 $127 Million
Q1 2019 May 13, 2019	SELL	$111.31 - $131.02 $16.5 Million - $19.4 Million	-148,187 Reduced 10.89%	1,212,113 $157 Million
Q4 2018 Feb 12, 2019	SELL	$105.9 - $118.64 $2.13 Million - $2.39 Million	-20,156 Reduced 1.46%	1,360,300 $157 Million
Q3 2018 Nov 13, 2018	BUY	$85.86 - $107.31 $4.9 Million - $6.12 Million	57,056 Added 4.31%	1,380,456 $148 Million
Q2 2018 Aug 13, 2018	SELL	$75.7 - $86.88 $23,769 - $27,280	-314 Reduced 0.02%	1,323,400 $113 Million
Q1 2018 May 08, 2018	SELL	$74.21 - $87.6 $66.8 Million - $78.8 Million	-899,554 Reduced 40.46%	1,323,714 $102 Million
Q4 2017 Feb 14, 2018	SELL	$81.94 - $87.89 $936,410 - $1 Million	-11,428 Reduced 0.51%	2,223,268 $188 Million
Q3 2017 Nov 15, 2017	BUY	$77.07 - $85.54 $172 Million - $191 Million	2,234,696	2,234,696 $191 Million

Others Institutions Holding LLY

# of Institutions

3,712

Shares Held

738M

Call Options Held

7.09M

Put Options Held

7.24M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $779B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Account

Neuberger Berman Group LLC Eli Lilly & CO Transaction History